Status:
COMPLETED
TAP Versus Thoracic Epidural in Major Abdominal Resections
Lead Sponsor:
Corewell Health West
Conditions:
Malignant Neoplasm of Abdomen
Surgery
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to compare two standard methods of pain control management used at Spectrum Health for patients undergoing major surgery. The two methods being compared are the thoracic e...
Detailed Description
The purpose of this study is to compare the clinical profiles of two currently acceptable analgesia techniques in terms of incidence of hypotension with subsequent fluid administration and pain contro...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- All patients male or female \>18 years old who are scheduled to undergo a major abdominal surgery. Abdominal procedures include, but are not limited to: pancreaticoduodenectomies, distal pancreatectomies, bowel resection, liver resection, esophagectomies, heated intraperitoneal chemotherapy, retroperitoneal excisions and large genitourinary procedures
- Patients determined by their surgeon as medically able to receive a thoracic epidural or a TAP block interchangeably after consideration of both procedures
- Patient agrees to participate in this study and provides informed consent
- Exclusion criteria:
- Surgical cases combined with thoracic surgeries
- Surgical cases where the abdominal operation is performed laparoscopically
- Patients that have allergies to lidocaine, bupivacaine, levobupivacaine or hydromorphone
- Patients that are on anticoagulation or antiplatelet medications at time of surgery other than aspirin
- Surgical cases that typically do not require a regional block in addition to general anesthesia (e.g., cutaneous operations)
- Adults unable to provide informed consent
- Children
- Pregnant women
- Prisoners
- Non-English speaking subjects
- Any other medical condition including mental illness or substance abuse deemed by the investigator to be likely to interfere with a subject's ability to provide informed consent, cooperate and take part in this research study
Exclusion
Key Trial Info
Start Date :
December 3 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2016
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT02197988
Start Date
December 3 2013
End Date
August 1 2016
Last Update
April 17 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Spectrum Health
Grand Rapids, Michigan, United States, 49503